Review discusses regulatory effects of micrornas on tgf-beta signaling and th9 differentiation in t cells, suggesting deeper insights into immune responses.
Since the discovery of microRNAs (miRNAs) in 1993, they have been established as key post-transcriptional regulators of immune cell function. In particular, miRNAs have emerged as key modulators of CD4+ T cell activation and differentiation. Accumulating evidence indicates that miRNAs influence CD4+ T cell fate through modulating transforming growth factor β (TGF-β) signaling, which negatively regulates T helper (Th) 1 and Th2 cell differentiation, while promoting the generation of regulatory T (Treg) cells, Th17 as well as Th9 cells. Despite these advances, our understanding of specific roles of miRNAs and their target molecules in CD4+ T cells remains limited, particularly in Th9 cells. In this review, we discuss the regulatory networks of miRNAs targeting the TGF-β signaling pathway in CD4+ T cells, with a special focus on their roles in Th9 cell differentiation and function.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: